These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23785046)

  • 21. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in the Th1/Th2 phenotype of memory T-cell clones from rheumatoid arthritis synovium.
    Aarvak T; Chabaud M; Källberg E; Miossec P; Natvig JB
    Scand J Immunol; 1999 Jul; 50(1):1-9. PubMed ID: 10404044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3.
    Nielsen M; Nissen MH; Gerwien J; Zocca MB; Rasmussen HM; Nakajima K; Röpke C; Geisler C; Kaltoft K; Ødum N
    Blood; 2002 Feb; 99(3):973-7. PubMed ID: 11807001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 Cells.
    Bock CN; Babu S; Breloer M; Rajamanickam A; Boothra Y; Brunn ML; Kühl AA; Merle R; Löhning M; Hartmann S; Rausch S
    Front Cell Infect Microbiol; 2017; 7():261. PubMed ID: 28676845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Fujita H; Ohmatsu H; Kakinuma T; Kadono T; Tamaki K; Sato S
    J Invest Dermatol; 2010 Sep; 130(9):2304-11. PubMed ID: 20505746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of VIP on the balance between cytokines and master regulators of activated helper T cells.
    Jimeno R; Leceta J; Martínez C; Gutiérrez-Cañas I; Pérez-García S; Carrión M; Gomariz RP; Juarranz Y
    Immunol Cell Biol; 2012 Feb; 90(2):178-86. PubMed ID: 21445087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NLRP3 Regulates IL-4 Expression in TOX
    Huanosta-Murillo E; Alcántara-Hernández M; Hernández-Rico B; Victoria-Acosta G; Miranda-Cruz P; Domínguez-Gómez MA; Jurado-Santacruz F; Patiño-López G; Pérez-Koldenkova V; Palma-Guzmán A; Licona-Limón P; Fuentes-Pananá EM; Lemini-López A; Bonifaz LC
    Front Immunol; 2021; 12():668369. PubMed ID: 34220814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
    Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
    Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.
    Dummer R; Kohl O; Gillessen J; Kägi M; Burg G
    Arch Dermatol; 1993 Apr; 129(4):433-6. PubMed ID: 8466213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.
    Estaquier J; Idziorek T; Zou W; Emilie D; Farber CM; Bourez JM; Ameisen JC
    J Exp Med; 1995 Dec; 182(6):1759-67. PubMed ID: 7500020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D in Cutaneous T-Cell Lymphoma.
    Ødum AF; Geisler C
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL).
    Jones EA; Pringle JH; Angel CA; Rees RC
    Leuk Lymphoma; 2002 Jun; 43(6):1313-21. PubMed ID: 12153001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells.
    Tokura Y; Yagi H; Seo N; Takagi T; Takigawa M
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):946-54. PubMed ID: 11044831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
    Jyonouchi H; Sun S; Winship T; Kuchan MJ
    J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas.
    Bagot M; Nikolova M; Schirm-Chabanette F; Wechsler J; Boumsell L; Bensussan A
    Ann N Y Acad Sci; 2001 Sep; 941():31-8. PubMed ID: 11594580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.